Cell and gene therapy manufacturers turn to specialist automation partners
These partnerships suggest that automation is becoming a practical priority for the cell and gene therapy industry.
Themes
Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory
Turning AI skeptics into AI advocates through high-integrity data
Keeping pace with generative AI in pharmaceutical and healthcare organisations
ECRD 2026: Navigating the rare disease diagnostic and drug development maze
ASCO26: Talzenna and Xtandi combo has first-line promise in HRR altered-mCSPC
Pharma Meets AI Conference 2026: Key barriers to scaling AI in drug development
Advancing pressure protection in biopharma: how integrated bypass technology elevates single-use pump design
